LifeVantage News

LifeVantage Introduces New Products, Training and Tools

Press Release | 11/7/2017

LifeVantage kicked off Elite Academy by announcing two new products: Omega+™ and Stacks. According to Chief Science Officer Nathalie Chevreau, Omega+ represents a new way to deliver the right combination of Omega 3s, Omega 7s, and Vitamin D in a high-end formula that’s purely sourced and completely traceable. Stacks combines the company’s best-selling products into different combinations designed to target specific health needs, helping further cement LifeVantage as a worldwide leader in biohacking.

“Biohacking is about helping our customers take control of their health to get the results they want,” said President and CEO Darren Jensen. “Stacks is a powerful line of nutrigenomic products that deliver on that vision with customized and targeted health solutions.”

LifeVantage also announced that the company has commenced a cross-border commercial pilot program in China. Still in commercial testing, the program will use an ecommerce model that is incremental to the traditional network marketing model LifeVantage conducts across the rest of its markets. The new model, powered by independent in-country social marketers, capitalizes on the rising trend of social entrepreneurism. The announcement was met with overwhelming response from attendees at the Elite Academy event, who participated in initial training on the innovative new ecommerce model.

Elite Academy also included several new technology announcements as LifeVantage continues to integrate advanced sales tools into its operations. Chief Marketing Officer, Ryan Goodwin, presented a revamped company website that simplifies the shopping experience for LifeVantage’s thousands of distributors across the world.

In addition, LifeVantage used Elite Academy to debut LifeVantage Digital—a new mobile app that provides distributors with all the functionality they need to build and run their businesses. This app will let distributors streamline their day-to-day operations by helping them manage everything from contacts and presentations to reporting and analysis from their mobile devices by using artificial intelligence and machine learning.

Business and personal development continued as important themes throughout Elite Academy, especially when world renowned author, coach and speaker John C. Maxwell took the stage on Saturday morning. Maxwell, the author of several New York Times best-selling books including The 21 Irrefutable Laws of Leadership, returned to Elite Academy to speak about the power of personal growth. According to Maxwell, personal growth is a lifelong journey that takes practice designed to increase capacity.

LifeVantage Appoints Charles J Wach COO

Press Release | 3/11/2017

“We are pleased to have Charles ‘Chuck’ Wach join the company as COO,” said LifeVantage President and Chief Executive Officer, Darren Jensen. “He is an accomplished leader with operations experience in the nutritional supplement, direct selling, online retail, and global food and beverage industries. His proven skills will help us to enhance our operations and deliver shareholder value. Additionally, Chuck’s supply-chain expertise and relationships with suppliers and manufacturers across salient product categories will expand our sourcing and manufacturing resources, broadening our supply chain and increasing efficiencies.”

“I am genuinely honored and excited to join the talented leaders at LifeVantage,” said Wach. “I look forward to safeguarding and strategically expanding the company’s well-curated, efficacious product portfolio. It is a true privilege to join such an incredible company, and I’m confident that my team and I will deliver new value to our distributors, shareholders and LifeVantage itself.”

Mr. Wach brings more than 30 years of operations and leadership experience, having served in multiple senior operational roles with relevant industry experience. Most recently, Mr. Wach served as Vice President of Operations and Supply Chain Executive for Bodybuilding.com, Inc., a global internet specialty retailer, from 2013 to 2017. Mr. Wach also served as Director of Global Supply Chain, Materials Management for Nature’s Sunshine Products, Inc. He has filled several operational roles for Nestle-Perrier Group of America Inc., H.J. Heinz Co., and Frito Lay, Inc. Mr. Wach received his Master of Business Administration degree from Utah State University and his Bachelor of Science degree in Finance from Brigham Young University.

LifeVantage Announces Protandim NRF1 Product Cyber Launch

Press Release | 4/24/2016

SALT LAKE CITY, April 21, 2016 -- LifeVantage Corporation will be hosting a live cyber event on May 17, 2016 at 6:00 PM MDT, to launch its much-anticipated Protandim NRF1 product. The launch event will be broadcast worldwide and will be shown live at lifevantage.com/live.

The Protandim NRF1 Synergizer is formulated to strengthen the mitochondria, which are the powerhouse of all cells, for better cellular health. It is designed to work in tandem with the company's flagship Protandim Nrf2 Synergizer product and further enhance the body's ability to naturally produce antioxidants and reduce the effects of cellular stress on its own.

"I see the launch of Protandim NRF1 further catapulting LifeVantage to success," said LifeVantage President and Chief Executive Officer, Darren Jensen. "Our focus on Nutrigenomics and having the two leading Nutrigenomic products in the world are two major factors that will shape the future of this company."

LifeVantage Launches PhysIQ Weight Management System

Press Release | 12/17/2015

“Our objective is to have a cohesive product offering that is unique and exclusive to LifeVantage, and provides optimal health for everyone,” said LifeVantage President and Chief Executive Officer, Darren Jensen. “PhysIQ fits perfectly within our philosophy of science-based products that are safe, effective, and easy to share. It is a comprehensive product line formulated to immediately begin to recharge and rebalance the body’s internal weight management system. PhysIQ is distinctively positioned to meet the rising market demand for weight management products.”

According to The Global Weight Loss and Diet Products Industry Report, in 2014 the weight loss and weight management market represented a staggering $148 billion worldwide, $64 billion in the United States alone.

LifeVantage Launches TrueScience Micro Lift Serum

Press Release | 10/30/2015

SALT LAKE CITY -- LifeVantage Corporation, has launched TrueScience Micro Lift Serum for immediate distribution in the United States. The TrueScience Micro Lift Serum is a natural way to instantly diminish the look of crow's feet, baggy skin, and dark circles around the eyes. In as little as 3 minutes, it visibly tightens, smooths, and firms the skin around the eyes, quickly restoring a youthful looking radiance without sacrificing long-term skin health. The TrueScience Micro Lift Serum pairs with the revolutionary TrueScience(TM) Skin Care system and is only available from LifeVantage.

"Customers today expect instant results from the products they use," said LifeVantage President and Chief Executive Officer Darren Jansen. " Our TrueScience Micro Lift Serum is in alignment with our strategy of offering demonstrable and effective products. It's the ideal companion to our TrueScience skin care system that uses proven ingredients to take years off of your appearance and now provides instant and long term anti-aging benefits."

LifeVantage Launches Sports Science Lab With Real Salt Lake

Press Release | 5/21/2015

"By monitoring the player's individual responses to training stress, the Sports Science Team at Real Salt Lake can more closely adjust workout and recovery regimens, cellular stress profiles, and nutrition and supplement interventions," said Shawn Talbott, PhD., Chief Science Office at LifeVantage Corporation. "Their ability to benchmark and measure oxidation, inflammation and biochemistry within the cellular stress profiles of their players will directly impact their on-field performance."

"We are very excited for our club to venture into this space, one occupied by only a handful of the biggest soccer franchises in the world," said Barlow, who has served as the club's Strength and Conditioning coach since 2007, noting that this program follows innovations currently in operation at Barcelona, Real Madrid, and select NFL teams. "The expansion of our performance baselines and the in-depth monitoring of our athletes would not be possible without the commitment and guidance of our LifeVantage partners."

LifeVantage and Real Salt Lake have cooperatively established baseline measurements and generated data on each player's nutritional makeup, strength and conditioning maintenance and growth, as well as recovery from games and practice regimens. The individual's response and progress will be continuously monitored, and each of the club's athletes will receive detailed oversight and instruction throughout the 10-month season, designed to achieve maximum performance and health, on and off the field.

LifeVantage Appoints New CEO

Press Release | 5/4/2015

Mr. Jensen most recently served as President of the Americas and Chief Sales Officer at Jeunesse Global, a personal care and nutrition network marketing company. During his tenure at Jeunesse, the company was ranked #258 on The 2014 Inc. 500 with 1788% revenue growth over a three-year period, and was the fastest growing Direct Selling Association company in America for 2014.

"LifeVantage is uniquely positioned as one of the leading product-driven business opportunities available," said Jensen. "I am honored and delighted to work together with our independent distributors to execute our vision of bringing that opportunity to the world."

Jensen brings 25 years of global network marketing and direct selling experience to LifeVantage from companies selling a variety of product types including nutritional supplements and personal care products. In addition to his tenure at Jeunesse Global, Mr. Jensen previously served in senior roles at USANA Health Sciences, Synergy Worldwide, Amway Global, and Nu Skin Enterprises. In these roles he led the development and execution of global sales, product development and service expansion strategies. He was responsible for international business development, performance improvement, and global marketing efforts in more than 100 countries within the Asia Pacific Rim, Latin America, the Caribbean, Europe, the Middle East, and Africa.

"Darren Jensen is a well-known and a respected visionary leader in the global network marketing and direct selling industry," said Garry Mauro, Chairman of the Board of Directors for LifeVantage Corporation. "The Board quickly recognized that Darren's unparalleled track record of success with leading the development and execution of business expansion and sales growth strategies makes him the right leader for LifeVantage."

LifeVantage Launches Operations in Thailand

Press Release | 3/28/2015

"At the beginning of this fiscal year, we disclosed our plan to expand operations into Thailand during fiscal 2015," said LifeVantage Executive Vice Chairman Dave Manovich. "The World Federation of Direct Selling Associations reports that Thailand is a market of more than 11 million distributors that generated total revenues of more than $3 billion in 2013. We believe our expansion into Thailand is directly in-line with our commitment to expand our operations into countries that we believe represent long-term growth opportunities."

LifeVantage Hosts Business Building Event for Women

Press Release | 3/15/2015

In addition to the world-renowned keynote speakers, top-level female independent Distributors and corporate executives from LifeVantage Corporation hosted sessions designed to educate women about the benefits of owning their own business, marketing and selling to men as well as other women, and what it means to be a successful businesswoman with the company.

"This first-ever "empowering women" event exceeded all of my expectations," said Dave Phelps, Chief Sales Officer at LifeVantage Corporation. "With more than 1,300 of our women business partners in attendance, the business and self-development training featured during these 3 days resulted in life-changing, vision-expanding and business-building experiences for the women of LifeVantage. They left Las Vegas with increased understanding of their potential for building a strong, sustainable business powered by strong residual income."

LifeVantage Announces Executive Management Change

Press Release | 2/3/2015

Furthermore, the Board has created an interim Office of the President consisting of LifeVantage's Senior Operational Officers to provide seamless leadership continuity and continued execution across the Company's strategic initiatives and oversee day to day operations. Dave Manovich will oversee the Office of the President and manage the strategic and tactical direction of the Company's operations until a new CEO has been appointed.

The Interim Office of the President will be made up of Shawn Talbott (Chief Science Officer), David Phelps (Chief Sales Officer), David Colbert (Chief Financial Officer) and Bob Urban (Chief Operating Officer). Additionally the other members of the senior executive team, Rob Cutler (General Counsel and Corporate Secretary) and Michelle Oborn (Vice President of Human Resources), will also report directly to Dave Manovich.

"On behalf of the entire company, I would like to thank Doug Robinson for his leadership and contributions to LifeVantage over the last five years," said Gary Mauro, Chairman of the Board. "We appreciate his hard work and dedication to growing our company's footprint, ensuring our transition from retail to network marketing, positioning our distributors for the next phase of growth and strengthening our product line. We wish him the best in his future endeavors.

"We are very pleased Dave Manovich has accepted the position of Executive Vice Chairman and we believe this change will lead to greater success for our distributors and improved long-term growth for our shareholders. We have a very strong management team and distributor base and are confident that the leadership transition will be seamless," concluded Mr. Mauro.

"After having discussions with the Board, I have concluded that it is in the best interests of the Company to step down from my position as President, CEO and Board Member," said Mr. Robinson. "I am incredibly proud of what we have achieved during my tenure, and while I will miss everyone at LifeVantage, I'm confident the Company's exceptional team of talented employees, distributors and leadership will ensure its best days are ahead."

Mr. Manovich has been an investor in LifeVantage for over a decade, an independent member of LifeVantage's Board of Directors since January 2012 and has extensive experience in executive sales and marketing operations and distribution management and development. He currently serves as Managing Partner of D&S Investments, a private investment entity and has held several executive level positions throughout his career with leading technology companies including COO of @Road Inc., Executive Vice President for worldwide sales at Apple Computer and Vice President of Sales for Fujitsu P.C. Mr. Manovich received an MBA in Finance and started his career as a CPA with Deloitte, Haskins and Sells.

LifeVantage Named One of 100 Fastest Growing Companies in Utah

Press Release | 10/26/2014

The Utah 100 honors three categories: the 100 fastest growing companies in Utah, the 15 Emerging Elite and the top 15 revenue growth companies. The Top Revenue Growth Companies are those businesses that have experienced significant revenue gains from year to year. Ranking this year was based on revenue growth from 2009 through 2013. This marks 20 years of the Utah 100 and is a milestone for the MountainWest Capital Network.

"We are honored to be recognized as one of the 100 fastest growing companies in Utah for a third consecutive year," said Douglas C. Robinson, LifeVantage President and Chief Executive Officer. "We know that thousands of eligible companies throughout the state of Utah apply for this honor so our ability to not only qualify for this ranking but also advance to the 3rd position is a testament to the hard work and dedication of our Independent Distributors and employees."

LifeVantage Launches New Skin Care LIne

Press Release | 4/27/2014

SALT LAKE CITY, April 25, 2014 -- LifeVantage Corporation, a company dedicated to helping people achieve healthy living through a combination of a compelling business opportunity and scientifically validated products, has launched a revolutionary beauty system consisting of a full line of anti-aging skin care products with enhanced Nrf2 technologies under its existing TrueScience brand. The new regimen was initially unveiled at the company's Annual Global Convention, held April 23-26, 2014, in Salt Lake City.

The full TrueScience skin care regimen consists of four products: TrueScience(TM) Ultra Gentle Facial Cleanser, TrueScience(TM) Perfecting Lotion, TrueScience(TM) Eye Corrector Serum, and TrueScience(TM) Anti-Aging Cream, which is an enhanced version of the company's existing anti-aging facial cream. The regimen has been tested in an independent third-party clinical study and has been shown to reduce the visible signs of aging by utilizing Nrf2 technologies to mitigate the visible effects of skin damage caused by oxidative stress. When used together, this regimen offers cumulative anti-aging benefits and provides protection against the environmental assault on the skin that consumers will be able to see and feel. Studies show that, in just four weeks, the skin appears renewed, visibly younger, brighter and more even-toned.

The products are available immediately and will be sold through the company's Distributor network and to Preferred Customers in all markets where LifeVantage currently operates. The complete four-product regimen is being offered at $160, or customers may elect to purchase each product individually, with prices ranging between $25 and $70. All products are free of parabens, GMOs, gluten, petrolatum, mineral oils, and artificial colorants.

Douglas C. Robinson, President and Chief Executive Officer of LifeVantage, stated, "We are excited to introduce our new skincare line. These products leverage our significant research on Nrf2 and oxidative stress as well as the TrueScience brand. We worked closely with the world's foremost skin care experts to create a regimen that is unique, shows great results and is priced competitively within the prestige beauty category. We look forward to working with our strong base of distributors to expand awareness of our newest products."

Dr. Shawn Talbott, Chief Science Officer of LifeVantage, commented, "When LifeVantage launched the TrueScience Anti-Aging Cream, it represented the best Nrf2 technology and anti-aging science available at the time. This enhanced and expanded anti-aging beauty system builds upon the existing technology, and these four products work together to go beyond wrinkles to address the visible signs of aging.

LifeVantage Acquires New Product Line From Wicked Fast Sports Nutrition

Press Release | 4/15/2014

SALT LAKE CITY, Apr 15, 2014 -- LifeVantage Corporation, a company dedicated to helping people achieve healthy living through a combination of a compelling business opportunity and scientifically validated products, today announced that it has acquired a line of sports nutrition products known as Wicked Fast Sports Nutrition. The products were designed and tested by LifeVantage's Chief Science Officer, Shawn Talbott, prior to joining LifeVantage. Dr. Talbott, an avid triathlete with 17 Ironman competitions under his belt, developed the Wicked Fast Sports Nutrition products to help both the serious and casual athlete feel better and perform better, regardless of their exercise and life goals. LifeVantage will conduct additional research and testing on the supplements and plans to rebrand the products in preparation for their official launch through its distribution network beginning in fiscal year 2015.

Douglas C. Robinson, President and Chief Executive Officer of LifeVantage, stated, "Our acquisition of Wicked Fast Sports Nutrition is in-line with our key initiative to expand our product offerings with scientifically backed, efficacious products that help individuals feel better, look better, and perform better. This also underscores our ability to grow our business through acquisition as well as through internal product development."

Dr. Talbott commented, "We are excited to integrate the Wicked Fast Sports Nutrition supplements into the LifeVantage product portfolio. These products are extremely effective in helping athletes of all levels recover after rigorous physical activity. This acquisition marks our entry into the large market of sports nutrition and supports our goal of providing safe and high quality products to individuals around the world striving to improve their health and fitness levels."

LifeVantage Recognized as Second Fastest Growing Company in Utah

Press Release | 9/21/2013

The Utah Business magazine Fast 50 recognizes 50 of the fastest growing companies in Utah, celebrating them for their entrepreneurial spirit, innovative business tactics, and skyrocketing revenue growth. Companies are selected based on a combination of revenue growth and total revenue on a year-over-year basis.

"It is an honor to be recognized for the second consecutive year," said Douglas C. Robinson, LifeVantage President and Chief Executive Officer. "Accelerating our continued growth is important, and so is maintaining our stability, so that LifeVantage remains prosperous for our customers, independent distributors, and shareholders for years to come. As we expand our reach throughout the world, we will stay committed to being a solid and steady company in our home state of Utah and beyond."

LifeVantage Awards 55 Jeeps to Top Distributors

Press Release | 8/14/2013

"The My LifeVenture program reflects our company's culture of promoting self-fulfillment, expanding personal horizons and seizing life's adventure," says LifeVantage President and Chief Executive Officer Douglas C. Robinson. "As a network marketing company, we have attracted some 65,000 individuals to market our science-based, healthy-living products as independent distributors in the U.S., Asia and beyond. Our products, like Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, are distinguished by impressive scientific research; our distributor training and support is the best in the industry. But we wanted to establish a new benchmark for distributor recognition and reward. Giving away Jeep Wranglers - vehicles that embody freedom, adventure, family and fun - makes this exciting new program totally unique and utterly appropriate for our healthy-living mission."

Distributors who qualify for Jeeps don't simply get the keys and the right to pick their custom accessories; they're enrolled in the My LifeVenture experience - an endless calendar of special adventures, like caravanning up Pikes Peak, Colorado, in late July, and exploring Coeur D'Alene, Idaho in August. Some of the excursions will be designed to leverage the Jeeps' free-wheeling, off-road capabilities, while others will showcase the smooth ride on open highways, but all will provide memorable bonding opportunities for everyone involved.

"The impressive anti-aging research that supports LifeVantage's products has always been a powerful tool to recruit distributors and customers for Protandim, TrueScience(R) Anti-Aging Cream and LifeVantage Canine Health," says Tyler Daniels, one of LifeVantage's top distributors and a resident of Richfield, Utah. "But the decision to become a distributor goes beyond the products. We're drawn to this company by the culture it promotes - integrity, family and improving the lives of others - and the freedom from financial concerns that it delivers."

Daniels, who took delivery of his super-accessorized Jeep in Denver, says, "The vehicle is not just an end, it's a means - to encourage our LifeVantage families to seize the day and get the most out of life. It's also an important tool to inspire our newer and future distributors to go the extra distance in marketing LifeVantage's remarkable business opportunity and products. My LifeVenture is like no other program in the network marketing industry."

An up-and-coming LifeVantage distributor, teenager Dillon Delaney of Tucson, Arizona, offers another perspective. "The Jeeps are awesome; they appeal to the younger generation because they represent fun and adventure," Delaney says. "I started representing LifeVantage because I believed in their products. I was blown away by all the lives that LifeVantage and its distributors had changed. I've grown my business rapidly for a little over a year and I'm already enjoying a substantial cash flow. The new My LifeVenture program," he says, "has put me into overdrive. Taking title to a Jeep, customized to my own specs, will be a dream come true."

Vehicles have been used in other companies' programs, but they usually come with strings attached, such as leases or revocation clauses for failure to maintain sales volume. "Giving clear and permanent title to cars is a unusual incentive," Robinson notes. "It's our way of celebrating and helping to fulfill our Elite-level distributors' personal and professional dreams."

LifeVantage Expands International Operations in Canada

Press Release | 6/4/2013

Previously, LifeVantage has sold its products, Protandim(R), the Nrf2 Synergizer(R) and TrueScience(R) Anti-Aging Cream on a limited basis to preferred customers in Canada, but did not offer the opportunity for interested customers to participate in the company's business opportunity. Effective June 5, however, the company will be accepting applications for independent distributors in Canada and will begin paying commissions to qualified independent distributors later during the month of June.

"For nearly two years, our distributors and preferred customers have demonstrated a substantial demand for our products and business opportunity in Canada," said LifeVantage President and Chief Executive Officer Douglas C. Robinson. "We also realize that a large opportunity exists for network marketing growth in the country. The World Federation of Direct Selling Associations reported a market of approximately 700,000 distributors and sales of $2.2 billion in 2011 in Canada. We believe an expansion into Canada is, therefore, directly in-line with our commitment to increase operations in countries that we believe represent long-term growth opportunities."

Mr. Robinson continued, "We will begin our Canadian expansion by continuing to offer both Protandim(R) and TrueScience(R) to preferred customers and now distributors in Canada, and expect to offer our new LifeVantage Canine Health product in Canada in the future."

With this expansion into Canada, LifeVantage is now doing business in the United States, Canada, Mexico, Japan, Hong Kong and Australia.

LifeVantage Announces 3rd Quarter Fiscal 2013 Results

Npros.com | 5/11/2013

Fiscal 2013 Third Quarter Highlights:

•Net revenue increased 39% to $50.4 million compared to same period last year; •Gross profit increased to $43.5 million compared to $31.2 million in same period last year; •The number of active independent distributors increased to approximately 63,000 as of March 31, 2013, compared to 55,000 as of December 31, 2012 and 37,000 as of March 31, 2012; and •The Company completed $5 million stock repurchase program announced on December 15, 2012.

Douglas C. Robinson, President and Chief Executive Officer of LifeVantage, stated, "Third quarter top-line results were affected significantly by the transition to an on-the-ground operation in Japan and our prior quarter voluntary product recall of Protandim. However, with the recall behind us and the transition in Japan further along, we believe we are better positioned to regain revenue momentum in the coming quarters."

Mr. Robinson continued, "With the introduction of our Canine Health product, our growing geographic presence that now includes operations in Hong Kong, and expected improvements in our operating margins, we are in a stronger position as we near the end of our 2013 fiscal year and move into fiscal 2014. During the third fiscal quarter, we continued our strategic infrastructure investment, with a focus on scaling our business in fiscal year 2014 and beyond. With record attendance at our recent Annual Global Convention in Salt Lake City, the high energy confirmed the on-going dedication of our distributors. Through a number of key initiatives, primarily LifeVantage University and the MyLifeVenture recognition program, we are better educating and engaging our distributors and expect this will help drive our top-line growth in fiscal 2014."

"Based on our projected revenue growth and our expected improvements in operating cash flow, we are pleased to announce that we have engaged D.A. Davidson as our advisor to pursue a $30-$40 million dollar credit facility. We intend to use these funds to repurchase shares of our common stock. This repurchase will be in addition to the current $5 million share buyback that was authorized in March 2013 and is expected to commence shortly."

LifeVantage Canine Health Earns Quality Seal from NASC

Press Release | 4/10/2013

The Quality Seal assures consumers that manufacturers have met rigorous quality control and labeling standards, and have passed a comprehensive quality system audit. The Seal program is part of the non-profit NASC's effort to promote consumer access to superior health and nutritional supplements for companion animals - primarily dogs, cats and horses.

"We are proud to display the NASC Quality Seal on our Canine Health product," said LifeVantage President and Chief Executive Officer Douglas C. Robinson. "The Seal underscores our commitment to offering innovative, science-based products of the highest quality for people and the animals we love."

Robert Urban, the company's Chief Operating Officer, added, "Quality assurance is ingrained in every aspect of LifeVantage's work, from research and development to product delivery and beyond. We are always looking for ways to enrich our offerings, with new science, new ingredients and new manufacturing processes. We continue to improve all of our products, including Canine Health. For us, earning the NASC Seal of Quality is recognition of an on-going job being well done."

LifeVantage Introduces Canine Health Product

Press Release | 1/24/2013

The Canine Health product was developed by LifeVantage in conjunction with renowned veterinarian and authority on animal nutrition, William Barnett, DVM, who has nearly 40 years of experience in veterinary medicine and in bringing products to market designed to improve animal health. Canine Health includes the same natural active ingredients as Protandim, at dosage levels specifically formulated for dogs, as well as omega-3 fatty acids and Type II collagen. These ingredients have been shown to reduce oxidative stress, support brain, heart and eye function, as well as normal joint structure and function.

"Protandim was developed to promote healthy living by helping people reduce age-related symptoms at the cellular level," said LifeVantage President and Chief Executive Officer Douglas C. Robinson. "Like humans, dogs suffer from oxidative stress, and research shows that canine companions can benefit from the same active ingredients contained in our patented flagship product, Protandim.

"Canine Health has been clinically tested in collaboration with Dr. Craig Woods, DVM, of Animal Health Consultants in Prescott, Arizona in a double-blind, placebo-controlled, multi-site study that demonstrates the safety and benefits of the product." Robinson added, "We have also gone a step further--adding vital ingredients already widely used to maintain pet health--to make Canine Health a convenient, all-in-one supplement and the only product in the world that is specifically formulated to treat oxidative stress in pets."

According to a leading authority on oxidative stress in pets, Dr. Maureen McMichael, DVM, DACVECC, Associate Professor of Veterinary Medicine at the University of Illinois, "LifeVantage Canine Health meets all criteria for a safe, easily administered, appealing product that targets multiple oxidative stress pathways in canines. My primary research focus has been the cause and treatment of oxidative stress in animals and humans so I am very excited to recommend this product to pet owners. Based on my research and on statistics from the American Pet Products Association, which show 39 percent of U.S. households have dogs--numbering more than 78 million--I believe there is a great need for Canine Health among pets."

LifeVantage to Present at the Sidoti Semi-Annual Micro-Cap Conference

Press Release | 1/1/2013

The LifeVantage Corporation investor presentation is scheduled for Monday, January 7, 2013, at 8:00 am Eastern Time.

LifeVantage Announces Shares Repurchase Program

Press Release | 12/15/2012

The repurchase program permits LifeVantage to purchase shares from time to time through a variety of methods, including in the open market, through privately negotiated transactions or other means as determined by the company's management, in accordance with applicable securities laws. As part of the repurchase program, the Company expects that it will enter into a pre-arranged stock repurchase plan which would operate in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934. Accordingly, transactions, if any, under the pre-arranged repurchase plan would be effected in accordance with the terms of the stock repurchase plan, including specified price, volume and timing conditions.

"Given the underlying strength of our business and the recent turbulence in the equity markets, we believe the stock buy-back program is in the best interests of our stockholders," Douglas C. Robinson, LifeVantage President and CEO, stated. "We intend to implement this buyback program while maintaining sufficient resources to continue to improve our balance sheet and invest in future expansion opportunities."

LifeVantage Corporation Announces Voluntary Recall

Press Release | 12/6/2012

Protandim is packaged in a cylindrical blue bottle and contains thirty caplets per bottle. The potentially affected Protandim® lot numbers are shown below. The lots shown below were distributed between July and November 2012. Lot numbers are located on the left side of the product label when looking at the front of the label, directly above the RFID scan bar.

Lot # Expiration Date 12-0258 7/2/2015 12-0259 7/3/2015 12-0292 7/9/2015 12-0294 7/11/2015 12-0295 7/12/2015 12-0304 7/18/2015 12-0306 8/16/2015 12-0307 8/17/2015 12-0373 8/21/2015 12-0382 9/21/2015

When the Company was alerted to this issue, it immediately isolated affected product and began working with its third party manufacturers, suppliers and industry experts to mitigate any health risk potential. After consulting with medical experts, the Company believes that these materials pose no serious risk to consumers' health. Furthermore, the Company has not received any report of a health problem related to this issue.

Douglas C. Robinson, President and CEO of LifeVantage, stated "Everyone at LifeVantage is deeply committed to providing the safest, most pure products for our distributor network and customers. In keeping to that high standard, the Company is offering to replace all bottles of the potentially affected product. We are confident that our network marketing distribution model will allow us to efficiently contact all those affected by this issue."

Robinson continued, "In addition, we have implemented even more stringent, industry-leading measures, including several redundant measures, in our manufacturing process. First and foremost, we will always strive to do what is in the best interest of our customers."

Consumers who have received bottles of Protandim® from the lot numbers identified above are encouraged to cease use of such product. The Company will immediately reach out to potentially affected consumers. Consumers having questions may contact LifeVantage directly by calling 866-912-9051 twenty-four hours per day.

LifeVantage to Present at the Wedbush 2012 California Dreamin Consumer Conference

Press Release | 11/27/2012

The LifeVantage Corporation investor presentation is scheduled for Tuesday, December 11, 2012, at 1:20 pm Eastern Time. The presentation will be webcast live and archived on the Investor Info portion of the Company's website at http://investor.lifevantage.com/events.cfm .

LifeVantage Lawsuit Dismissed

Press Release | 11/14/2012

LifeVantage Makes a Donation to the Against Malaria Foundation

Press Release | 11/13/2012

According to Against Malaria founder Rob Mather, the equivalent of seven jumbo jets full of children under the age of five die from malaria every day. "And every single one of those deaths is completely avoidable through the use of a simple mechanical barrier--a mosquito net," Mather said. "The 24,000 mosquito nets that will be purchased and donated to those in need with the funds generously provided by LifeVantage and its independent distributors will save hundreds of lives and thousands more will be spared the devastating effects of malaria."

The fundraising event took place in conjunction with LifeVantage's quarterly training event held in Las Vegas, Nevada, October 26-27, 2012. Those in attendance participated in two days of transformational training by independent distributor leaders, presentations by nationally renowned advertising and marketing expert and motivational speaker Roy Spence and corporate executives, as well as a surprise performance by LifeVantage Spokesperson Donny Osmond.

"We express our sincere appreciation to each member of the LifeVantage family for their support of our philanthropic efforts, specifically their donations for the benefit of the Against Malaria Foundation and the thousands of families worldwide that they serve," said President and CEO Douglas C. Robinson. "We are very honored to help people everywhere with healthy living and quality of life--not just through our products and business opportunity, but through our charitable efforts as well."

The Company gives back and makes a positive impact in the world by partnering with respected service organizations during corporate events held each quarter. For more information about Against Malaria, go to www.againstmalaria.com .

LifeVantage Announces First Quarter Fiscal Year 2013 Results

Press Release | 11/9/2012

Fiscal 2013 First Quarter Highlights Compared to the Same Period Last Year Include: -- Net revenue increased 163% to $52.9 million; -- Operating income grew 101% to $6.9 million; -- Net income increased to $4.2 million or $0.03 per diluted share. Douglas C. Robinson, President and Chief Executive Officer of LifeVantage, stated, "We are pleased with our strong start to fiscal 2013. We built off our momentum from last fiscal year and once again delivered solid top and bottom line growth on a year-over-year basis. Demand for and interest in our scientifically validated products continues to attract an increasing number of independent distributors and preferred customers. As a result of our first quarter performance and outlook for the remainder of the year, we are reiterating our previously issued guidance range."

Mr. Robinson continued, "With our record growth last year and projections for another record year in fiscal 2013, we plan to continue investing in our business to ensure that we have the proper foundation in place for healthy, long-term growth that is sustainable for many years. As an example, we recently invested in our international operations with the grand opening of our new Tokyo office, which we believe will enable us to further expand our presence in the Japanese market. In addition, we are exploring the opportunity to enter Hong Kong. We also are investing in our core United States operations in areas such as personnel, including our recently announced appointment of Dr. Darlene Walley as our new Chief Science Officer. Dr. Walley will oversee our research and development efforts as we look to expand our offering of scientifically validated, research-backed products. While the financial impact of these and other infrastructure investments will cause some fluctuation in our operating margins during the year, we remain confident that we will achieve our annual operating margin target and generate strong profitability in fiscal 2013."

Mr. Robinson concluded, "We are very pleased with the overall strength of our business which enabled us to list our common stock on the NASDAQ Capital Market. This had been a goal of ours, and we are very proud to have completed this important step toward achieving long-term shareholder value for our company."

LifeVantage Appoints New Chief Science Officer

Press Release | 10/16/2012

Dr. Walley will directly oversee the expansion of the Company's research and development as it seeks to expand its offering of scientifically validated research-backed products. Prior to joining LifeVantage, Dr. Walley was founder and president of DRW Consulting, a firm specializing in assisting large and small companies in bringing new products to market. Her clients spanned the nutraceutical, pharmaceutical and biotechnology industries. In addition, Dr. Walley has led research and development teams at Procter & Gamble, as Senior Director of Research and Development at Church & Dwight, and as Vice President of Research and Development at Gillette. Dr. Walley has a Ph.D. in Chemistry from the University of Cincinnati and a B.A. in Chemistry from Case Western Reserve.

In connection with Dr. Walley's appointment, the Company also announced today that Dr. Joe McCord will continue to work with the Company to champion third-party peer reviewed studies of the Company's flagship product Protandim and to educate the increasing number of independent distributors on the advancement of Nrf2 science. Dr. McCord will remain a key member of the Company's Scientific Advisory Board, which will be led by Dr. Walley.

"We are excited to have Darlene leading our research and development team and believe her strong background in bringing products to market combined with our leading position in Nrf2 science will enable us to expand our healthy living product offerings," said Douglas C. Robinson, President and CEO. "We want to thank Dr. McCord for his leadership as our Chief Science Officer and his enduring legacy with Protandim and are grateful that he will continue to champion Protandim in the scientific community as well as with our independent distributors on our behalf."

"LifeVantage is a fast-growing company with many opportunities, and I am eager to be a strategic member of the team," stated Darlene Walley. "I plan to utilize my background with nutraceutical and cosmeceutical product development to bring new products to market and strengthen the scientifically validated products available to LifeVantage global consumers."

LifeVantage Announces Record Fourth Quarter and Full Fiscal Year 2012 Results

Press Release | 9/11/2012

SALT LAKE CITY, Sept. 10, 2012 -- LifeVantage Corporation, a company dedicated to helping people achieve healthy living through a combination of a compelling business opportunity and scientifically validated products, including its patented dietary supplement Protandim®, the Nrf2 Synergizer®, today reported financial results for the fourth quarter and full year ended June 30, 2012.

Fiscal 2012 Fourth Quarter Highlights Compared to Same Period Last Year Include:

- Net revenue increased 197% to $44.6 million; - Operating margin increased to 16.5% compared to 13.0%; - Operating income grew 275% to $7.3 million.

Fiscal 2012 Full Year Highlights Compared to Fiscal 2011 Full Year Include:

- Net revenue increased 224% to $126.2 million; - Operating margin increased to 17.0% compared to 9.5%; - Operating income grew 480% to $21.5 million; - Cash and cash equivalents grew to $24.6 million as of June 30, 2012 from $6.4 million as of the prior year-end.

Douglas C. Robinson, President and Chief Executive Officer of LifeVantage, stated, "We are pleased to report a strong fourth quarter and a record full year for fiscal 2012. Growing demand for and interest in our products combined with a stronger distributor base and infrastructure enabled us to increase our annual revenue by 224%, increase operating income by 480% and exceed the top end of our previously issued guidance range."

Mr. Robinson continued, "In fiscal 2012, we made strategic investments into our infrastructure and personnel in corporate administration, finance, marketing, operations, sales and R&D in order to put the necessary platform in place for us to continue our strong growth. As we begin fiscal 2013, we are excited about the opportunities ahead of us. In addition to continuing our strong organic growth in the core United States market, we plan to expand our international presence and enter new markets as well.

"Our financial and operating improvements in fiscal 2012 have also enabled us to achieve a listing on The NASDAQ Capital Market for our common stock. This event marks a major milestone in LifeVantage's history and will be an important step in achieving long-term shareholder value for our company."

Mr. Robinson concluded, "As we enter fiscal 2013, we believe we are well-positioned to deliver another record year of revenue and operating income growth. We look forward to updating you on our progress throughout this year."

NASDAQ Capital Market Listing

The Company announced today that its common stock has been approved for listing on The NASDAQ Capital Market. Shares of LifeVantage's common stock are expected to commence trading on the NASDAQ Capital Market under its current ticker symbol "LFVN," effective at market opening on September 12, 2012.

Fiscal Year 2013 Guidance

The Company anticipates continued strong growth in fiscal 2013. LifeVantage expects to generate revenue for fiscal 2013 in the range of $250 million to $260 million. The Company expects to generate operating income in the range of $34.5 million to $38.2 million, and an operating margin of 13.8% to 14.7%. The Company expects to generate earnings per diluted share in the range of $0.18 to $0.20, based on estimated weighted average diluted shares outstanding of 129 million.

Conference Call Information

The Company will hold an investor conference call today at 2:30 p.m. Mountain time (4:30 p.m. Eastern time). Investors interested in participating in the live call can dial (888) 587-0613 from the U.S. International callers can dial (719) 457-2710. A telephone replay will be available approximately two hours after the call concludes and will be available through Wednesday, September 12, 2012, by dialing (877) 870-5176 from the U.S., or (858) 384-5517 from international locations, and entering confirmation code 8430189.

There also will be a simultaneous, live webcast available on the Investor Relations section of the Company's web site at http://investor.lifevantage.com/events.cfm. The webcast will be archived for approximately one year.

LifeVantage Appoints David Colbert as New Chief Financial Officer

Press Release | 8/7/2012

Mr. Colbert will oversee all financial and accounting activities for the Company and will serve as the Company's principal financial officer. Prior to joining the Company, Mr. Colbert, age 43, was the Vice President and Chief Financial Officer of Park City Group, Inc., a publicly held software-as-a-service company. Prior to joining Park City Group, Inc. in July 2010, Mr. Colbert was co-founder, Chief Financial Officer and Vice President of Operations for Sendside Networks, Inc., a privately held software-as-a-service company. Earlier in his career, Mr. Colbert spent 14 years with Kimberly-Clark Corporation, a Standard & Poor's 500 company, where he held various positions of increasing responsibility in finance, accounting and strategic planning. In his final Kimberly-Clark role, Mr. Colbert was responsible for all accounting, reporting and strategic analysis for a wholly-owned subsidiary. Mr. Colbert holds a Bachelors degree in Finance and Marketing from the University of Iowa and an MBA from Emory University.

"We are excited to have David join our management team and believe his strong financial background combined with his strategic planning and public company experience will provide a meaningful contribution to our company as we continue to build our team and infrastructure," said Douglas C. Robinson, President and CEO. "In addition, we believe David will be instrumental in supporting our continued profitable growth, geographic expansion and the strategic introduction of new and complementary products."

"LifeVantage has incredible opportunities ahead as more consumers become aware of its position as a leader in Nrf2 science," commented David Colbert, Chief Financial Officer. "I am very excited to be given the opportunity to apply my experience in overseeing rapidly growing companies and my financial expertise to help the company grow with the changing marketplace."

Mr. Robinson concluded, "We want to thank Carrie for her years of service to LifeVantage. Her strategic and operational excellence have been key to our rapid growth over the last three years and she has led the effort to ensure that we can continue forward with a solid financial foundation. We appreciate her willingness to help facilitate David's transition and continue to positively position LifeVantage for the coming years."

LifeVantage Donates to Hunger Relief International

Press Release | 7/23/2012

Hunger Relief International, a nonprofit organization headquartered in Oklahoma City, Oklahoma, was established in 2009. Hunger Relief International works to feed children utilizing locally grown food sources in the countries and regions in which they operate. According to Hunger Relief International Executive Director Rachel Zelon, "The meals provided by LifeVantage and its Independent Distributors are the extension of a loving arm to children in desperate need in Haiti and Guatemala and we are overwhelmed with gratitude for the LifeVantage family and their generous contribution to those in need."

"We are extremely pleased to partner with respected organizations working, as we are at LifeVantage, to make the world a better place," said Douglas C. Robinson, LifeVantage President and CEO. "We remain committed to reducing oxidative stress, improving quality of life and enabling people to enjoy a higher quality of life. We sincerely appreciate the generosity of the LifeVantage family and are grateful for their enthusiastic support of LifeVantage Legacy service efforts."

In addition to the meals provided for orphans and underprivileged children, through the LifeVantage donation, Hunger Relief International will also be able to provide vegetable gardens and training in cultivation and gardening for several orphanages, educational programs for children, training programs for adults as well as health care in poor, rural areas of Guatemala.

Through LifeVantage Legacy, LifeVantage Corporation seeks to make a positive impact globally by partnering with respected service organizations during corporate events held each quarter. The company gives back and improves the quality of life of people around the world by raising funds and awareness of the organizations they serve.

LifeVantage Corporation Expands Management Team

Press Release | 6/1/2012

"We are gratified to lead the fight against oxidative stress, primarily through Nrf2 activation, and because leading companies lead—they never follow—it's critical we continue to have the right people in place to help us further our objectives and accomplish our strategies," said Douglas C. Robinson, President and CEO. "Each new role on our management team brings valuable experience that will be instrumental in accommodating distributor growth, continued profitable growth, geographic expansion and the strategic introduction of new and complementary products."

The LifeVantage Management Team includes the following new roles:

Robert M. Urban, Chief Operating Officer (COO): Mr. Urban oversees global operations, infrastructure and the efficiencies associated with that to support the continued growth of LifeVantage. His operational experience includes program and project management, process reengineering, systems integration, mechanical and test engineering as well as human resources, finance, benefits administration, time and absence management, payroll and labor relations. Mr. Urban received a B.S. in Mechanical Engineering and a minor in Business Administration from Gonzaga University and earned his Executive Masters in Business Administration from the University of Washington.

Rob Cutler, General Counsel: Mr. Cutler provides support to all departments of LifeVantage related to its ongoing growth and expansion. He is also responsible for LifeVantage legal and risk management matters worldwide. He received a B.A. in Finance from the University of Utah, a juris doctorate from Brigham Young University and has focused his career advising national and multi-national companies, including biotech and pharmaceutical corporations in both a legal and business development capacity.

Brandon K Butterfield, VP Marketing and Communications: Mr. Butterfield oversees the Company's strategic marketing efforts including the creation and communication of its international brand, products, events, investor relations and sales support globally, as well as all corporate communications efforts. His professional background includes marketing, product development, ecommerce, social media, integrated communications and finance and he received a B.S. in Marketing with a minor in Economics from Utah State University.

Kirby Zenger, Chief Network Officer: Mr. Zenger, former Chief Operating Officer of LifeVantage, is now responsible for the Company's global networking operations, working closely with LifeVantage independent distributors to achieve sales revenue and growth. Mr. Zenger has decades of experience in sales, marketing, branding, operations and international expansion and is highly regarded in business circles as well as the direct sales industry.

LifeVantage Announces Record Third Quarter Fiscal Year 2012

Press Release | 5/16/2012

SALT LAKE CITY, May 15, 2012 -- LifeVantage Corporation, the leader in Nrf2 science and the maker of Protandim®, the Nrf2 Synergizer™ patented dietary supplement, today reported financial results for the third quarter and nine months ended March 31, 2012.

Fiscal 2012 Third Quarter Highlights Include:

Net revenue increased 263% to $36.2 million compared to same quarter last year; Operating margin increased to 17.7% compared to 7.9% in the same quarter last year; Operating income grew 709% compared to the same quarter last year to $6.4 million; Cash and cash equivalents were $16.9 million with no debt; Stockholders' Equity increased to $22.5 million compared to a Stockholders' Deficit of $(20.8) million as of June 30, 2011.

Fiscal 2012 Third Quarter Results

For the third fiscal quarter ended March 31, 2012, the Company reported record net revenue of $36.2 million, compared to $10.0 million for the same period in fiscal 2011, an increase of 263%. On a sequential quarter basis, net revenue increased 43% from the $25.3 million reported for the Company's 2012 second fiscal quarter ended December 31, 2011.

Gross profit for the fiscal quarter ended March 31, 2012 increased to $31.2 million, compared to $8.4 million for the same period last year, delivering a gross margin of 86.2%, compared to 84.1% for the same period last year.

Operating expenses for the third fiscal quarter decreased as a percent of revenue to 68.5%, or $24.8 million, compared to 76.2% of revenue, or $7.6 million, for the same period last year. On a sequential quarter basis, operating expenses as a percentage of revenue were relatively flat. The increase in the amount of operating expenses is due primarily to increased sales commissions which are a direct result of the Company's higher sales volume. This increase in the amount of operating expenses also reflects greater investment in personnel and infrastructure to position the Company for future growth.

Operating income improved to $6.4 million for the third fiscal quarter, compared to $0.8 million in the same period last year and $4.3 million in the second fiscal quarter. This was the Company's seventh consecutive quarter of achieving operating income. Operating income margin was 17.7% in the third fiscal quarter, compared to 7.9% in the same period last year and 16.9% in the second fiscal quarter.

Fiscal 2012 First Nine Months Results

For the nine months ended March 31, 2012, the Company reported record net revenue of $81.6 million, compared to $23.9 million for the same period in fiscal 2011, a 242% increase. Operating income increased to $14.1 million, compared to $1.7 million in the same period last year.

Douglas C. Robinson, President and Chief Executive Officer of LifeVantage, stated, "We are pleased to report another record quarter for LifeVantage, as we continue to execute on all fronts and achieve tremendous growth for our business. In the third quarter, we significantly increased our top line as well as our operating margins while continuing to invest in our infrastructure by adding headcount, increasing our marketing efforts, and expanding our investment in research."

Mr. Robinson continued, "At the beginning of this fiscal year, we outlined a plan for significant investment in our infrastructure and increasing personnel in corporate administration, finance, marketing, operations, sales and R&D. This investment is providing the necessary platform for us to continue our organic growth and position us to enter new markets. In addition to strong growth in our core United States market, we continue to benefit from international opportunities. Our business in Japan is achieving strong growth and we expect to be shipping product to Australia beginning this month."

Mr. Robinson concluded, "Mid-way through our final quarter of fiscal 2012, we are well-positioned to deliver another record year of revenue growth and operating profits. Our year-to-date results exceeded our expectation, and as a result, we are increasing our annual revenue and operating income guidance. We are excited to build off this positive momentum as we finish fiscal 2012 and look toward fiscal 2013 and beyond."

Balance Sheet & Liquidity

The Company improved its balance sheet in the third fiscal quarter. The Company's cash balance at March 31, 2012 was $16.9 million, an increase from $6.4 million at year end fiscal 2011, due to strong revenue growth and operating profits. The Company generated $11.7 million of cash flow from operations for the nine months ended March 31, 2012, compared to $2.4 million for the nine months ended March 31, 2011. Stockholders' Equity increased to $22.5 million as of March 31, 2012 compared to a Stockholders' Deficit of $(20.8) million as of June 30, 2011.

LifeVantage Announces Market Expansion at Record Breaking Convention

Press Release | 5/3/2012

SALT LAKE CITY, May 2, 2012 -- On the heels of recent inclusion in the Direct Selling News Global 100, a ranking of the top 100 companies in the direct sales industry worldwide, LifeVantage Corporation welcomed record numbers of Independent Distributors to Anaheim, Calif. for its annual Global Convention 2012, April 26-28.

Attendance at the annual event doubled over last year, while participation from outside the U.S. was up 500%, surpassing every previous LifeVantage event. Independent Distributors heard the breaking announcement of the Company's official expansion into Australia, with a soft launch into that market expected in May 2012. Independent Distributors also learned that the Company has initiated research to examine the effectiveness of reducing oxidative stress through Nrf2 activation in pets. Finally, LifeVantage and Protandim spokesperson, Donny Osmond, closed the convention with a motivating and inspiring concert.

"It's a very exciting time for LifeVantage -- we're accomplishing the strategic objectives we have set -- and we're being recognized by many, including the Direct Selling News Global 100, for our unprecedented growth and other successes," said Douglas C. Robinson, President and Chief Executive Officer. "We're confident in our efforts and our belief that we are leading the fight against oxidative stress, primarily through Nrf2 activation, resulting in a better quality of life for all."

Added Kirby Zenger, Chief Network Officer, "It's always a pleasure to gather as a Company with the finest leaders in our industry and to personally experience the record number of Independent Distributors joining us for our events as well as the heightened interest in our products everywhere."

LifeVantage Makes Charitable Donation to Traffic Jam

Press Release | 4/21/2012

Traffic Jam Campaign was founded by Paul Myhill, who also co-founded the predecessor company of LifeVantage Corporation in 2004. In 2006, Mr. Myhill stepped down from all his roles with the Company to focus on charitable endeavors and the Company generously gifted stock to a foundation under Mr. Myhill's trusteeship. In 2011, LifeVantage and many of its Independent Distributors again contributed to Mr. Myhill's charitable organization. Although in recent months, Mr. Myhill's communications in various social media forums created misunderstandings regarding the Company, LifeVantage and Mr. Myhill are pleased to announce that all areas of misunderstanding have been amicably resolved in full.

"We are pleased to make this significant contribution to Traffic Jam Campaign, an organization that is dedicated to improving the lives of children," said Douglas C. Robinson, President and CEO of LifeVantage.

"I express my gratitude to LifeVantage for today's generous contribution as well as its past contributions to further the mission of Traffic Jam Campaign, and I deeply regret any damage or confusion that may have been caused by my public remarks in recent months," Paul Myhill said. "I fully support LifeVantage and its mission, its corporate integrity, its marketing strategy and efforts, and its continued dedication to improving the quality of life for others. I recognize and appreciate the extensive contributions of Dr. Joe McCord and others in the Company in developing, testing and refining Protandim and acknowledge that credit for the current success of LifeVantage and Protandim belongs to many. I am honored to continue as a champion of LifeVantage, but remain primarily focused on my efforts toward helping children around the world."

Mr. Robinson continued, "Mr. Myhill shares our commitment to improving the lives of others and we are pleased to have resolved all of his concerns. LifeVantage remains dedicated to offering science based, research backed products that result in a better quality of life for all. Our flagship product Protandim has been reviewed and validated by investigators at highly respected universities and institutions and continues to be studied worldwide for its ability to reduce oxidative stress, primarily through the activation of Nrf2. We also remain committed to conducting our business, as always, with the highest degree of integrity and transparency."

Mr. Myhill is not a member of LifeVantage management and is not a spokesperson for the Company. All inquiries regarding LifeVantage and Protandim should be directed to the Company.

LifeVantage Featured in OTC Growth Stock Watch Newsletter

Press Release | 3/15/2012

LifeVantage is a science-based nutraceutical company that develops, manufactures and distributes a line of patented dietary supplements and anti-aging cosmetics. The Company's clinically proven formulations reduce oxidative stress, particularly activating the Nuclear factor (erythroid-derived 2) also known as Nrf2, which works on a cellular level. Flagship products include Protandim(R), the Nrf2 Synergizer(TM) patented dietary supplement, and the anti-aging skin care product, TrueScience(R). Products are sold in the U.S., Canada, Japan and Mexico through a growing network of independent distributors, preferred customers and direct-to-customers. Dr. Joe McCord, Ph.D., Chief Scientist of LifeVantage, has more than 40 years of research experience in free radical biology, oxidative stress and Nrf2 activation.

About OTC Growth Stock Watch

Based in Dover, MA, OTC Growth Stock Watch is a publication of OTC Research Corp., published since 1979, OTC Growth Stock Watch has earned its place as one of the most respected and referred-to guides to discovering high-performance growth stocks in the industry. OTCGSW has been regularly referenced by Barrons, Fortune, the Dick Davis Digest, CNBC's Market Mavens and other leading financial news sources.

Geared toward aggressive, growth-oriented investors, OTC Growth Stock Watch reports on companies with a market capitalization under $100 million, which meet a rigid set of financial criteria, niche-oriented products and services, and an annual minimal growth rate of 15%.

LifeVantage Announces Record Second Quarter

Press Release | 2/15/2012

Fiscal 2012 Second Quarter Highlights Include:

-- Net revenue increased 239% to $25.3 million compared to same quarter last year; -- Operating margin doubled to 16.9% compared to 8.2% in the same quarter last year; -- Operating income grew 603% compared to the same quarter last year to $4.3 million; -- Cash and cash equivalents were $13.5 million; -- Four new directors were elected to the Board, adding significant leadership experience; -- Received approval from warrant holders for and completed a tender offer to modify certain outstanding warrants such that the Company will no longer account for these warrants as a derivative liability, which the Company believes will enable its financials to more closely reflect operating performance. Fiscal 2012 First Six Months Results

For the six months ended December 31, 2011, the Company reported record net revenue of $45.4 million, compared to $13.9 million for the same period in fiscal 2011, a 226% increase. Operating income increased to $7.7 million, compared to $1.0 million in the same period last year.

Douglas C. Robinson, President and Chief Executive Officer of LifeVantage, stated, "Our record second fiscal quarter revenue and operating income, combined with the doubling of our operating margins, underscore our ability to achieve leverage in our business while making strategic investments. We plan to continue to strengthen our infrastructure by adding headcount for all areas of our business and increasing our marketing investments as we build the necessary platform to continue our profitable organic growth."

"As awareness and understanding about Protandim and LifeVantage TrueScience(R) Anti-Aging Cream continues to expand in consumer markets as well as among medical professionals, we believe that our business is positioned for continued long-term growth. We are seeing a growing number of distributors join our team, as evidenced by record attendance at our recent quarterly distributor convention. We look forward to building upon this positive momentum and delivering another record year for LifeVantage in fiscal 2012."

Mr. Robinson concluded, "Reflecting our commitment to continue enhancing our corporate leadership, our shareholders recently elected four new members of the Board of Directors. These directors add diverse and deep leadership experience to the Board and are a strong addition to our Company. We are very excited about our continued outlook for fiscal 2012 and look forward to continuing to achieve long-term growth and profitability while helping people around the world improve their health and wellness through the science of Protandim."

The Company will hold an investor conference call today at 2:30 p.m. Mountain time (4:30 p.m. Eastern time). Investors interested in participating in the live call can dial (877) 604-9665 from the U.S. International callers can dial (719) 325-4886. A telephone replay will be available approximately two hours after the call concludes and will be available through Thursday, February 16, 2012, by dialing (877) 870-5176 from the U.S., or (858) 384-5517 from international locations, and entering confirmation code 2407254.

There also will be a simultaneous, live webcast available on the Investor Relations section of the Company's web site at http://investor.lifevantage.com/events.cfm The webcast will be archived for 30 days.

LifeVantage Spokesperson Donny Osmond Appears on Dr Phil Show

Press Release | 2/11/2012

Donny Osmond, the 2009 "Dancing with the Stars" champion, said he had discovered what he called his own "fountain of youth"--Protandim--during his appearance on the Dr. Phil show. Donny added that he has taken Protandim for two years at his doctor's recommendation and has experienced many health benefits and anti-aging results.

"This continues to be an exciting time for Protandim and LifeVantage," said LifeVantage President and CEO, Douglas C. Robinson. "There is an ever increasing number of Nrf2 studies in many of the most respected universities and institutions around the world. It is also gratifying to know that Protandim is of such interest that people have been typing 'Protandim' in Google searches more than any other word recently."

About Protandim, the Nrf2 Synergizer

Protandim(R) is a clinically demonstrated supplement that provides substantial benefits for healthy aging. Nrf2 is a protein messenger contained in every cell of the body. When activated, Nrf2 enters the cell nucleus and turns on hundreds of survival genes, defensive, stress responsive, cytoprotective genes that enable cells to survive in the face of several different kinds of stress, particularly oxidative stress. This patented Nrf2-activating therapy works in a very different way than conventional antioxidant supplements. Unlike vitamin or carotenoid-containing products that have proven to be largely ineffective in reducing oxidative stress caused by free radicals, Protandim is an indirect antioxidant therapy, which stimulates the body's production of its own powerful antioxidant enzymes and other stress-related gene products. Protandim works at the cellular level, triggering cells to naturally increase production of protective antioxidant enzymes such as superoxide dismutase (SOD), catalase, and glutathione synthase, while decreasing production of pro-inflammatory signals. A peer-reviewed human clinical study showed that after Protandim was taken for 30 consecutive days, important biochemical markers of aging were decreased by an average of 40%. The study also reported that these markers of aging were reduced in the subjects taking Protandim to the level of a typical 20 year old. Protandim is currently the subject of several scientific studies at universities and research facilities. The nature and stages of the studies vary. Under the Dietary Supplement Health and Education Act, Protandim is considered a "dietary supplement". Protandim is not intended for the prevention, diagnosis, treatment, mitigation or cure of any disease.

LifeVantage to Announce Quarterly Results on February 14

Press Release | 2/8/2012

Investors interested in participating in the live call can dial (877) 604-9665 from the U.S. International callers can dial (719) 325-4886. A telephone replay will be available approximately two hours after the call concludes and will be available through Thursday, February 16, 2012, by dialing (877) 870-5176 from the U.S., or (858) 384-5517 from international locations, and entering confirmation code 2407254.

There also will be a simultaneous, live webcast available on the Investor Relations section of the Company's web site at http://investor.lifevantage.com/events.cfm . The webcast will be archived for 30 days.

LifeVantage to Present at ICR XChange Conference

Press Release | 1/4/2012

The LifeVantage investor presentation is scheduled for Thursday, January 12, 2012, at 9:25 am Eastern Time. The presentation will be webcast live and archived on the Investor Info portion of the Company's website.

About ICR XChange

The ICR XChange is one of the largest and most unique investor conferences of the year, and is open to institutional portfolio managers and analysts, sell-side research analysts, investment bankers from sponsoring firms only, private equity professionals, select media and invited guests of ICR. The event is expected to feature presentations by nearly 180 public and private companies, as well as, a variety of discussion panels and keynote presentations. Last year's attendance exceeded 1,500 institutional, corporate and media attendees, and this January ICR is expecting even greater participation. CNBC is also expected to broadcast live at the event for the sixth consecutive year.

LifeVantage Announces New Peer Reviewed Study

Press Release | 11/11/2011

Protandim(R), a patented dietary supplement comprised of five highly synergistic natural ingredients, was shown in earlier studies to activate the transcription factor Nrf2, a signal to the cell's DNA to regulate a network of protective genes. This new study further investigates Protandim's(R) ability to increase production of the body's Nrf2-regulated protective genes, sometimes referred to as "survival genes," which include genes that encode antioxidant enzymes, as well as anti-inflammatory and anti-fibrotic proteins.

The study, titled "Oxidative Stress in Health and Disease: The Therapeutic Potential of Nrf2 Activation" by Brooks M. Hybertson, Bifeng Gao, Swapan K. Bose, and Joe M. McCord, is published in the scientific journal Molecular Aspects of Medicine and may be found at the following link: http://www.ncbi.nlm.nih.gov/pubmed/22020111 .

"This study examined gene expression using Affymetrix(R) GeneChips and the relationships among the regulated genes using Ingenuity Pathway Analysis(R) in cultured human cells treated with Protandim(R)," said Dr. McCord, Chief Science Officer of LifeVantage and senior author of the study.

Thousands of genes were affected by Protandim(R) treatment, including prototypical Nrf2-dependent genes such as heme oxygenase-1. Pathway Analysis was utilized to glean insights from the upregulated and downregulated genes, and it revealed that many of the genes affected by Nrf2 activation are relevant to Alzheimer's Disease, atherosclerosis, and colon carcinoma, among other conditions. For the majority of the genes associated with these conditions by pathway analysis, Nrf2 activation in cultured cells regulated the genes in directions that opposed the changes produced by the disease processes.

Further, the study described a bioassay that allows for direct comparisons of efficacy among Nrf2 activators applied to cultured cells. The agents examined included Protandim(R) and sulforaphane, the well-studied Nrf2 activator found in broccoli, and two pharmaceutical Nrf2-activating products currently in phase 3 human clinical trials. One of these, bardoxolone methyl from Reata Pharmaceuticals/Abbott Laboratories, is a promising candidate for the treatment of chronic kidney disease in type II diabetes patients, based on their reported Phase 2 and Phase 3 human clinical trials to date. The other pharmaceutical product, BG-12 (dimethyl fumarate) from Biogen Idec, is a promising candidate for the treatment of relapsing-remitting multiple sclerosis, based on their reported Phase 2 and Phase 3 human clinical trials results to date. Both pharma products recognize Nrf2 pathway activation as the basis of their physiological activity.

"The early successes of Nrf2 activation in the treatment of diseases as disparate as kidney failure and multiple sclerosis bodes well for the future usefulness of Nrf2 activation, whether managed by pharmaceutical products, dietary supplements such as Protandim(R), or by diet itself," said Dr. McCord.

"Protandim(R) was shown in an earlier human trial to increase antioxidant enzyme production and to eliminate the age-dependent increase in the most widely used marker of oxidative stress," stated Douglas C. Robinson, Chief Executive Officer of LifeVantage. "The current study, as well as other recent studies, have shown that Protandim(R) may provide benefits to the body that extend beyond its ability to decrease oxidative stress. Scientific publications such as these help raise the profile and expand the awareness of our product, and we look forward to continuing to help a growing number of people achieve their health and wellness goals."

LifeVantage Announces Record Fiscal Year

Press Release | 9/30/2011

For the fourth fiscal quarter ended June 30, 2011, the Company reported record net revenue of $15.0 million compared to $4.4 million for the same period in fiscal 2010, an increase of 241% from the prior year period. On a sequential basis, net revenue increased 50% from the $10.0 million reported for the third fiscal quarter ended March 31, 2011.

Gross profit for the fourth quarter of fiscal 2011 increased to $12.9 million compared to $3.7 million for the same period last year, delivering an improved gross margin of approximately 86%, compared to 83% for the same period last year.

Operating expenses for the fourth fiscal quarter of 2011 were $11.0 million compared to $4.0 million for the same period last year, and on a sequential basis increased 45% from $7.6 million in the third fiscal quarter of 2011. The increase on a sequential basis is due primarily to increased sales commissions which are a direct result of the Company's increased revenue. The increase also reflects greater investment in personnel and infrastructure to position the Company for future growth.

Operating income improved to $2.0 million for the fourth fiscal quarter of 2011 compared to a loss of $290 thousand in the same period last year. The fourth quarter of fiscal 2011 is the Company's fourth consecutive quarter of achieving operating income. Operating income margin improved to 13% in the fourth quarter compared to a negative margin in the same period last year.

Douglas C. Robinson, Chief Executive Officer of LifeVantage, stated, "We are extremely pleased to report a record year for LifeVantage, as our strong financial performance underscores the expanding awareness of Protandim® and the successful execution of our business model. On an annual basis, our revenue more than tripled compared to last year, and we increased our operating income in each quarter of fiscal 2011. We also made significant improvements to our balance sheet and ended the year in a very healthy financial position, which provides us the financial flexibility to make the appropriate strategic investments in fiscal 2012 to support our long-term growth opportunities."

Mr. Robinson continued, "As the scientific support of Protandim® grows and more people seek our products to improve their overall health and wellness, it is important for us to have the appropriate infrastructure to support the continued growth that we believe our business is capable of delivering. Looking toward fiscal 2012, we anticipate that our total net revenue will more than double compared to fiscal 2011 and our operating income will also increase by over 100%. To ensure that we are positioned to sustain rapid growth for years to come, we are committed to making the appropriate investments in our sales and marketing departments, research and development efforts, and within our corporate infrastructure. We are very focused on improving the efficiency of our organization and continuing to increase our operating income while we make these investments."

For the full year ended June 30, 2011, net revenue increased 238% to $38.9 million from $11.5 million in fiscal 2010. Gross profit improved to $33.0 million in fiscal 2011 compared to $9.6 million in fiscal 2010. Operating income increased to $3.7 million in fiscal 2011, compared to an operating loss of $7.3 million in fiscal 2010. Operating income margin improved to 9.5% for the year compared to a loss for the prior fiscal year.

The Company ended fiscal 2011 with a much stronger balance sheet than when the year began. Its cash balance improved to $6.4 million due to strong revenue growth and operating profits generated by the business. The Company generated $4.7 million of cash flow from operations for the full year fiscal 2011 compared to a cash use from operations of $4.5 million in fiscal 2010. During fiscal 2011, an aggregate face value of $5.6 million in debt was converted into shares of the Company's common stock, eliminating all convertible debt.

Due to the improvements made to its balance sheet in fiscal 2011 as well as the Company's outlook for strong operating cash flow in fiscal 2012, the Company recently announced a share repurchase program that authorizes it to utilize up to $5 million to purchase common stock over the course of the twelve months beginning October 1, 2011. Any such repurchases will be made only out of free cash flow from continuing operations and, on a quarterly basis, will not exceed 50% of free cash flow for such quarter.

LifeVantage At Accredited Members Conference

Press Release | 6/10/2011

LifeVantage Small Cap Equity Review

Press Release | 6/2/2011

"Lifevantage Corporation is in the midst of a turnaround story, and investors who take a closer look at the company may find an idea most everyone else is overlooking while searching for something a little sexier," says Brumley. The declining sales trend seen between 2006 and 2008 has been reversed, in spades. Fiscal 2010's $11.5 million in revenue is a record, even if it was paired with a record loss of $11 million. The numbers and the way Lifevantage's fiscal calendar falls, however, may obscure something very compelling that's just unfolded in the last three quarters... the company has swung to a profit, and just posted its best quarterly sales ever. It managed to turn $10.0 million in revenue last quarter into a profit of $792,000. Brumley adds "Just to put it into perspective, this supplement distributor generated $7.46 million in revenue for the prior quarter (a record at the time), and generated $6.4 million in sales for the quarter before that (also a record at the time). The bottom line has been reliable too, with an operating per-share profit of $0.01 three quarters ago, what would have been about $0.01 worth of per-share profit two quarters ago (a big accounting benefit boosted the total), and it posted earnings of about $0.01 per share for the most recently-completed quarter." Unlike so many other pill and supplement makers/distributors, Lifevantage has something unique, effective, and patented - Protandim. This supplement improves a user's innate antioxidant protection, and the claim has been verified - repeatedly - in clinical studies. As such, the organization clearly has something that some corporations never find, which is a marketable product and a business model that works.

LifeVantage Announces New President

Press Release | 3/16/2011

LifeVantage previously announced that the Board of Directors had opened a search for a new CEO to take over corporate responsibilities while current CEO David Brown would focus his efforts exclusively on continuing to expand the Company's network marketing channel. Mr. Brown will now serve as President & CEO of the network marketing operations and will remain as a member of the Company's Board of Directors.

"We are pleased that Doug will be joining the Company as President and CEO," stated Garry M. Mauro, LifeVantage's Chairman of the Board of Directors. "He brings tremendous knowledge and expertise as a seasoned executive and having been a member of the Board he has extensive experience with the Company's business operations."

"Given the significant growth and momentum we have generated and the continued opportunity before us, I believe, as does the Board, that I can bring the most value to shareholders by focusing solely on continuing to grow revenue and expand the network marketing business," David Brown added. "Doug's expertise in management and financial operations and corporate governance are important assets as we seek to continue the rapid expansion and growth of our business."

Douglas Robinson most recently served as Chief Executive Officer of WorkWell Systems, a rapidly growing physical medicine and workers' compensation solutions company. He is a seasoned executive with extensive experience in the Healthcare industry, bringing over 20 years of relevant industry experience, including senior roles at UnitedHealth Group, Deloitte Consulting and PriceWaterhouseCoopers.

Mr. Robinson holds a B.A. degree in Marketing/Public Relations and Speech Communications from Gonzaga University, Spokane, Washington where he also continues to guest lecture on healthcare economics to the undergraduate and graduate schools.

LifeVantage Dubs Protandim BSCG Approved

Press Release | 3/3/2011

"Samples of Protandim® have been analyzed for anabolic agents and stimulants and no prohibited compounds were detected in the product," stated Oliver Catlin, of the BSCG in Los Angeles, CA. "As a result, we have issued a certification for Protandim® at this time. The BSCG seal lets customers know the product has been certified and does not contain dangerous banned substances."

"We are proud that Protandim® has been scrutinized and certified by the BSCG to ensure that consumers and athletes are able to take the product with confidence," stated David W. Brown, President & CEO of LifeVantage. "We are pleased to participate in a program which helps to differentiate between responsible supplement manufacturers, of which we strive to be, and those whose products may present unnecessary risks."

"According to the BSCG, athletes are held personally liable for any substances prohibited by the USADA, the IOC, the NCAA, and the NFL which may be present in their bloodstream, regardless of the substances' origins," stated Gene Tipps, Senior Vice President of Operations of LifeVantage. "For this reason, athletes must be extremely careful about what they put into their bodies. We have found that a substantial number of athletes feel supplements are a vital part of their training regimen and as such, we are proud to be able to provide a quality product to those in the sports arena, athletes as well as consumers."

According to their website, the BSCG was founded by professionals with years of experience in the field of anti-doping analytical work and the group addresses the concern that dangerous banned substances can be found in dietary supplements, even when these substances are not listed as ingredients. The BSCG assists responsible dietary supplement manufacturers by utilizing cutting edge anti-doping methodology to analyze and certify that a sample of their product was tested for a list of banned substances, and that no banned substances were found in that sample above certain detection limits. More information on the BSCG can be found on their website, www.bscg.org.

LifeVantage Press Release

Press Release | 2/3/2011

LifeVantage Searches For New CEO

Press Release | 2/2/2011

Highly-qualified candidates may request consideration in confidence, by contacting LifeVantage via phone (801) 432-9038 or email executivesearch@lifevantage.com, no later than Tuesday, February 15th, 2011.

"Given the significant growth and momentum we have generated and the continued opportunity before us, I believe, as does the Board, that I can bring more value to shareholders by focusing solely on continuing to grow revenue and expand the network marketing business," Brown said. Brown will continue to serve as corporate President and CEO until a successor is named and will continue to occupy a position on the Board.

LifeVantage CEO Refocuses On Marketing Channel

Press Release | 1/24/2011

LifeVantage recently announced that it anticipates reporting its highest net revenue to date of approximately $7.4 million for the three month period ended December 31, 2010, an increase of approximately $1.0 million or 15% over net revenue of $6.4 million reported in the previous three month period ended September 30, 2010, and an approximate $4.9 million or 196% increase in net revenue over the $2.5 million net revenue reported for the same quarter last year.

Along with recording net revenue of $7.4 million, the Company also anticipates operating income of at least $500,000 in the second fiscal quarter 2011. Operating income of $500,000 would generate nearly a 7% operating profit margin, compared to an operating loss of $2.7M for the same quarter last year.

"We are pleased to announce that we are exceeding our previous guidance and anticipate reporting our highest quarterly net revenue to date," stated Brown. "These results reflect the continued growth we have seen from both the U.S. and Japanese markets. We'd like to thank all of our distributors, customers and employees responsible for these record results."

LifeVantage Press Release

Npros.com | 3/9/2010

Aspenwood Capital partner Steve Ossello said, "The Aspenwood partners have always been tremendous supporters of the company and its primary product - Protandim®. The science behind Protandim is incredible and given the recent quality additions to the board and the significant growth LifeVantage is experiencing, we're very excited about its potential."

LifeVantage CEO and President David Brown said, "We are extremely pleased with Aspenwood's continued support. The quality of both the institutional and individual investors that they have brought to our company is truly remarkable. We're confirming that this raise provides the company with the capital it needs to get through profitability."

LifeVantage Announces Board Expansion

Npros.com | 1/29/2010

The new additions broaden the range of expertise in corporate governance and oversight, management and financial operations, as well as business development. David W. Brown, President and CEO of LifeVantage stated: "We are delighted to welcome Mike, Kay and Doug to our Board of Directors. They bring tremendous knowledge and expertise within their respective fields. "We believe their experience will be an important asset as we seek to continue the rapid expansion and growth of our business." Mike Lu has been involved with investment analysis and portfolio management for over 20 years and is currently an independent investor in public markets and private equity. Mr. Lu managed the Janus Global Technology Fund from 1999 to 2006.

Kay Stout Manovich is a branding strategist, with more than 30 years of experience in comprehending, analyzing and improving brand communications and has worked behind such companies as: Coca-Cola, Kodak, Pizza Hut, Gerber, RadioShack, Neutrogena, Frito-Lay, Wacoal, Maybelline, Amore Pacific and Healthline.com.

Douglas Robinson is the CEO of WorkWell Systems, a medicine and workers' compensation solutions company, and a long time Healthcare industry executive. Mr Robinson has over 20+ years of experience having served with multiple companies and health administrations and has been vital in guiding some of the earliest total replacement consumer-driven healthcare efforts for several Fortune 500 employers.

Mexican government approves LifeVantage Protandim

Npros.com | 1/8/2010

After a pre-launch in Mexico, LifeVantage announced its entry into the international market in mid to late 2009.

"I'm excited Protandim is finally in Mexico - it has been a long time in coming. We are

enthusiastic about the potential health benefits to all in Mexico who use Protandim as well as to the opportunities for future research that the availability of the product in Mexico will provide. I believe there is not another product like Protandim in Mexico." said Daniel Hernandez-Saavedra, director or research for the Biochemical Research Center within the National Medical Center of Mexico. Mr Saavedra is also a LifeVantage Scientific Advisory Board member.

"We believe that the availability of Protandim in Mexico is a great opportunity for consumers seeking to improve their health. Furthermore, with the arrival of Protandim in Mexico, in addition to the availability of our TrueScience Anti-Aging Cream, our distributors are now fully empowered to enjoy the increased financial benefits of the LifeVantage business opportunity." said Francisco Varela, the national sales director of Mexico for LifeVantage.

LifeVantage Announces First Quarter Revenue

SunHerald.com | 10/17/2009

Total operating expenses in the first fiscal quarter of 2010 decreased by approximately 25% from total operating expenses of $6.1 million in the fourth fiscal quarter of 2009. This decline is primarily attributable to reductions of approximately 80% in total legal expenses. In the first fiscal quarter of 2010, legal expenses decreased by approximately $1 million and other operating expenses decreased by approximately $0.5 million. These decreases are directly attributable to the Company's efforts in expense reductions and greatly reduced activity in litigation in which the Company has been a party.

LifeVantage Announces 4th Quarter 2009 Results

PR Newswire | 9/30/2009

The Company recorded net revenues of $4.1 million and a net loss of ($9.1) million, or ($0.23) per share, for its year ended June 30, 2009. For its year ended June 30, 2008, the Company recorded net revenues of $3.2 million and a net loss of ($2.1) million or ($0.09) per share.

During its fourth quarter fiscal year 2009, the Company recorded net revenue of $1.6 million, which represents an increase of approximately 150% from the net revenue of $0.6 million for the third quarter fiscal year 2009 and a net loss of ($5.3) million or ($0.11) per share. During its fourth quarter fiscal year 2008, the Company recorded net revenues of $0.8 million and a net loss of $(0.7) million, or $(0.03) per share.

LifeVantage granted third patent for Protandim

Npros.com | 9/3/2009

Click below for the complete press release.

LifeVantage Trims Operating Costs

Npros.com | 8/11/2009

LifeVantage Signs Agreement with Montel Williams

Press Release | 2/26/2009

Montel Williams commented, “My Living Well brand focuses on products and tools that are designed to promote a healthy lifestyle. I have been a fan of Protandim for several years and I feel the potential health benefits are numerous, making this an ideal fit with the other health and wellness products available via Living Well. Protandim significantly reduces oxidative stress, which is a key factor in many medical conditions and diseases, and I am excited to offer this outstanding product to health-conscious consumers.”

LifeVantage Makes Record Setting Announcement

Press Release | 2/17/2009

David Brown, LifeVantage President and CEO, said, "We are extraordinarily fortunate to join forces with Jason, Tyler, Marcell and their team. Their one year revenue growth record is legendary in the industry and we believe could significantly impact LifeVantage's rapid expansion into the network marketing sales channel. Every network marketing company in the industry would love to have this team and the fact that they chose to join us is a testament to the strength of the science behind Protandim® and that they share our belief that this can become a powerful, global brand."

LifeVantage to Present at ROTH Capital Partners

MarketWatch | 2/11/2009

LifeVantage PR Claims Protandim Results

Business Wire | 11/28/2008

Protandim®, a patented product developed by LifeVantage Corporation (OTCBB:LFVN), was proven by an earlier study to actually slow the progressive rate of aging. This new study confirms that Protandim’s® gene induction approach to antioxidant therapy provides much broader and more powerful benefits to the body than those provided by vitamins such as E and C, according to the Company.

LifeVantage Shows Loss for Year

MarketWatch | 9/27/2008

For its fourth fiscal quarter 2008, the Company recorded net revenues of $0.8 million and a net loss of $(0.7) million, or $(0.03) per share. For its fourth fiscal quarter 2007, the Company reported net revenues of $0.8 million and a net loss of $(0.5) million, or $(0.02) per share.

LiveVantage Announces Protandim Sales Increase

MarketWatch | 8/15/2008

SAN DIEGO, Aug 13, 2008 (BUSINESS WIRE) -- LifeVantage Corporation has announced it has increased distribution of Protandim(R) via a network of well-known regional brokers; the initiation of a direct sales program to healthcare professionals; and a partnership providing an entree into the fitness arena. According to Ben Seeman, LifeVantage's Vice President of Sales, "Upon joining the company approximately two months ago, my immediate focus was to accelerate product distribution within the United States. Leveraging my long standing relationships, we have created a strong network of brokers who have quickly brought on new retail accounts that are very excited about Protandim. Orders from these new accounts have already been received by the company." These new brokers include Contemporary Marketing, Inc.; Concept Sales and Associates; Colorado Natural Products; Gulf Coast Naturals; Fred Cordolla, LLC; and Steve Craner, LLC. LifeVantage is also seeing success in its new direct sales effort to doctors and healthcare professionals. Seeman commented, "The company's sales team is calling directly upon doctors, introducing them to a comprehensive new program that makes it easy for them to provide the tremendous benefits of Protandim to their patients. We have received a great response and new orders from this initiative. This effort aligns well with our new partnership with Chiropractic Buying Group, a company that provides information kiosks within chiropractic offices."

LifeVantage Appoints Richard Doutre Jones

Business Wire | 3/29/2008

David Brown, President and CEO of LifeVantage, commented, “Garry Mauro and Richard Doutre’ Jones are nationally recognized leaders in the business and civic sectors and we are honored to announce they have joined our Board of Directors. Mr. Mauro brings a legal, political and policy-making perspective to our Board, thanks to his impressive experience at the local, state and national level. He has an outstanding record in representing public and private sector interests, including serving a 16-year term as the Commissioner of the Texas General Land Office.”

LifeVantage Expands Global Marketing Initiatives

Business Wire | 3/12/2008

David Brown, President and CEO of LifeVantage commented, “Jan and Peter bring proven track records and unparalleled expertise to our creative, marketing, and communications agendas. Peter’s acumen in brand building, marketing, and sales, together with Jan’s proven success in leading early stage companies to rapid growth and high visibility, will move the LifeVantage team to a whole new level. We are extremely excited to partner with both individuals in the continued growth, expansion and success of this company.”

LifeVantage Announces 2Q 2007 Financials

Centre Daily Times | 2/22/2008

For the six month period ended December 31, 2007, the Company recorded net revenues of $1.6 million and a loss of $(0.7) million, or $(0.03) per share comparing to net revenues of $3.2 million and a loss of $(2.6) million, or $(0.12) per share for the six month period ended December 31, 2006.

LiveVantage Announces Asia Market Expansion

Centre Daily Times | 2/22/2008

According to LifeVantage President and CEO David Brown, "NutraNomics has an excellent reputation as an organization that is known for its ability to quickly achieve successful product launches in Asia. NutraNomics has a proven track record in obtaining wide distribution with the leading companies including Miki Shoji, Japan's largest direct marketing company with over 500,000 distributors. In addition, the company has strong relationships with Mitsui Busan, Watakura, and Kanebo, through which NutraNomics distributes products in the Asian retail sector."

Brown Named CEO of LifeVantage

Trading Markets | 1/16/2008

Nutrition Business Advisors was founded in 2003 to provide strategic consulting services, capital raising and full-service business development focused on the billion global nutrition industry. Prior to co-founding Nutrition Business Advisors, Brown was CEO of Metabolife International.

Greenwood Village, Colorado-based LifeVantage develops nutraceutical products, including Protandim, a dietary supplement.